GLPG-1837

DB16835InvestigationalSmall molecule

GLPG-1837: Overview.

Mechanism: Pharmacologically active on Cystic fibrosis transmembrane conductance regulator
Curator reviewed
Formula / weight: C₁₆H₂₀N₄O₃S · 348.42 g/mol (avg)
Code names: GLPG 1837

Resolves to

Compound

Structure

InChIKeyGHTGYZMBQPXTCQ-UHFFFAOYSA-NSMILESCC1(C)CC2=C(SC(NC(=O)C3=NNC=C3)=C2C(N)=O)C(C)(C)O1

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with GLPG-1837, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.